Showing results (121-130 of 177) with videos related to

Sort By:
Pageof 18
Transplantation and Cellular Therapy|April 4, 2023
Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell TransplantationJuliana Vergara-Cadavid, P Connor Johnson, Haesook T Kim, et al.
Blood Advances|May 15, 2024
Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor overall survivalRoman M Shapiro, Haesook T Kim, Remy Dulery, et al.
Blood|February 14, 2018
α<sub>1</sub>-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host diseaseJohn M Magenau, Steven C Goldstein, Dan Peltier, et al.
Blood|April 14, 2016
Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host diseaseJohn Koreth, Haesook T Kim, Kyle T Jones, et al.
Transplantation and Cellular Therapy|June 13, 2025
An ASTCT, CIBMTR, EBMT, and APBMT Consensus Statement Defining Response Criteria for Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy (TA-TMA) Directed Therapy: Consensus Response Criteria for TA-TMAMichelle L Schoettler, Eleni Gavriilaki, Enric Carreras, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2018
Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention TrialsMarcelo C Pasquini, Brent Logan, Richard J Jones, et al.
Haematologica|January 13, 2018
Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II resultsJohn Koreth, Haesook T Kim, Paulina B Lange, et al.
Blood Advances|May 7, 2020
BK virus-specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantationEduardo Espada, Matthew P Cheng, Haesook T Kim, et al.
Bone Marrow Transplantation|October 17, 2019
A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiationZachariah DeFilipp, Shuli Li, David Avigan, et al.
Blood Advances|April 3, 2019
Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host diseaseRoger Belizaire, Haesook T Kim, Samuel J Poryanda, et al.
Pageof 18